This course was last updated on
March 31, 2017
CME credit has expired.


Biff F. Palmer, MD, and Robert Toto, MD, address challenges encountered when preventing and managing hyperkalemia in patients with chronic kidney disease, as well as how best to incorporate potassium binding therapy for hyperkalemia. The questions presented in this activity were posed by nephrologists who attended a related series of live, CME-certified meetings.

Check your own knowledge with 5 short assessment questions.

Discover the top questions nephrologists have about hyperkalemia.

Probe the details of a related patient case.

Content Areas

  • Chronic kidney disease
  • RAASi therapy
  • Potassium binding therapy

Target Audience

This activity was developed for nephrologists, nephrology nurses, fellows and other health care professionals who have an interest in the management of hyperkalemia.

This activity was supported by an educational grant from Relypsa, Inc.


Biff F. Palmer, MD
Biff F. Palmer, MD
Professor of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas
Robert Toto, MD
Robert Toto, MD
Associate Dean, Clinical and Translational Research
Director, Center for Translational Medicine
UT Southwestern Medical Center
Dallas, Texas
Enter your information to begin.
CME Credit
Available Credit: 1.00 AMA PRA Category 1 Credit™.
1.00 ANCC Contact Hour
Course Opens: March 31, 2017
Course Expires: March 30, 2018
Target Audience: Nephrologists
Nephrology Nurses
Other Health Care Providers
Activity Resources